Literature DB >> 24111729

Validation of acute liver injury cases in a population-based cohort study of oral antimicrobial users.

Christine L Bui, James A Kaye, Jordi Castellsague, Brian Calingaert, Lisa J McQuay, Nuria Riera-Guardia, Catherine W Saltus, Scott C Quinlan, Crystal N Holick, Peter M Wahl, Kiliana Suzart, Kenneth J Rothman, Mari-Ann Wallander, Susana Perez-Gutthann1.   

Abstract

We conducted a cohort study of acute, noninfectious liver injury among oral antimicrobial users. Potential cases were identified in the HealthCore Integrated Research Database (HIRD(SM)) population between July 1, 2001, and March 31, 2009, using ICD-9-CM codes primarily for acute and subacute necrosis of the liver, hepatic coma, and unspecified hepatitis. Liver test results were used to confirm case status according to published criteria. Two physician reviewers experienced in studying acute liver injury (blinded to study drug exposures) evaluated data abstracted from hospital and emergency department records to validate potential cases. Of 715 potential cases having claims associated with any of the primary screening codes, 312 (44%) were valid cases, 108 (15%) were not cases, and 295 (41%) were of uncertain status (records inadequate for validation). Among potential cases with adequate medical records, the PPV for presence of any of the primary codes was 74% (95% CI, 70%-78%). The highest PPV for a single code was for acute and subacute necrosis of the liver (84%; 95% CI, 77%-90%). Evaluation of cases of noninfectious liver injury using hospital and emergency department medical records continues to represent the preferred approach in studies using insurance claims data.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24111729     DOI: 10.2174/15748863113086660051

Source DB:  PubMed          Journal:  Curr Drug Saf        ISSN: 1574-8863


  5 in total

1.  Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation.

Authors:  Alvaro Alonso; Richard F MacLehose; Lin Y Chen; Lindsay Gs Bengtson; Alanna M Chamberlain; Faye L Norby; Pamela L Lutsey
Journal:  Heart       Date:  2017-01-05       Impact factor: 5.994

2.  Risk of Acute Liver Injury in Agomelatine and Other Antidepressant Users in Four European Countries: A Cohort and Nested Case-Control Study Using Automated Health Data Sources.

Authors:  Manel Pladevall-Vila; Anton Pottegård; Tania Schink; Johan Reutfors; Rosa Morros; Beatriz Poblador-Plou; Antje Timmer; Joan Forns; Maja Hellfritzsch; Tammo Reinders; David Hägg; Maria Giner-Soriano; Alexandra Prados-Torres; Miguel Cainzos-Achirica; Jesper Hallas; Lena Brandt; Jordi Cortés; Jaume Aguado; Gabriel Perlemuter; Bruno Falissard; Jordi Castellsagué; Emmanuelle Jacquot; Nicolas Deltour; Susana Perez-Gutthann
Journal:  CNS Drugs       Date:  2019-04       Impact factor: 5.749

3.  Validity of ICD-9 and ICD-10 codes used to identify acute liver injury: A study in three European data sources.

Authors:  Joan Forns; Miguel Cainzos-Achirica; Maja Hellfritzsch; Rosa Morros; Beatriz Poblador-Plou; Jesper Hallas; Maria Giner-Soriano; Alexandra Prados-Torres; Anton Pottegård; Jordi Cortés; Jordi Castellsagué; Emmanuelle Jacquot; Nicolas Deltour; Susana Perez-Gutthann; Manel Pladevall
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-06-06       Impact factor: 2.890

4.  Validation of a claims-based algorithm identifying eligible study subjects in the ADAPTABLE pragmatic clinical trial.

Authors:  Ezra Fishman; John Barron; Jade Dinh; W Schuyler Jones; Amanda Marshall; Rebecca Merkh; Holly Robertson; Kevin Haynes
Journal:  Contemp Clin Trials Commun       Date:  2018-11-10

5.  Active Pharmacovigilance of Drug-Induced Liver Injury Using Electronic Health Records.

Authors:  Sang Heon Kim
Journal:  Allergy Asthma Immunol Res       Date:  2020-05       Impact factor: 5.764

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.